TransAct (TACT) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

TACT Stock Forecast


TransAct stock forecast is as follows: an average price target of $9.00 (represents a 126.70% upside from TACT’s last price of $3.97) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

TACT Price Target


The average price target for TransAct (TACT) is $9.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $9.00 to $9.00. This represents a potential 126.70% upside from TACT's last price of $3.97.

TACT Analyst Ratings


Buy

According to 1 Wall Street analysts, TransAct's rating consensus is 'Buy'. The analyst rating breakdown for TACT stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

TransAct Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 13, 2024TransAct TechnologiesCraig-Hallum$9.00$5.8853.06%126.70%

The latest TransAct stock forecast, released on Mar 13, 2024 by TransAct Technologies from Craig-Hallum, set a price target of $9.00, which represents a 53.06% increase from the stock price at the time of the forecast ($5.88), and a 126.70% increase from TACT last price ($3.97).

TransAct Price Target by Period


1M3M12M
# Anlaysts--1
Avg Price Target--$9.00
Last Closing Price$3.97$3.97$3.97
Upside/Downside-100.00%-100.00%126.70%

In the current month, the average price target of TransAct stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to TransAct's last price of $3.97. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Mar 13, 2024Craig-HallumBuyBuyHold

TransAct's last stock rating was published by Craig-Hallum on Mar 13, 2024. The company gave TACT a "Buy" rating, the same as its previous rate.

TransAct Financial Forecast


TransAct Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
Revenue--------$13.27M$17.19M$19.91M$22.27M$17.96M$17.86M$12.62M$9.70M$11.12M$10.64M$9.32M$8.30M$7.76M$7.30M$5.29M$10.25M$11.16M$11.69M$11.35M$11.55M$12.24M$14.00M
Avg Forecast$12.77M$12.92M$13.02M$12.18M$10.39M$12.09M$10.46M$11.39M$13.60M$16.19M$18.45M$17.59M$16.90M$13.82M$10.44M$11.12M$10.18M$9.44M$8.33M$8.02M$7.66M$7.17M$5.08M$11.18M$11.50M$14.46M$13.37M$12.19M$16.32M$11.14M
High Forecast$13.21M$13.37M$13.47M$12.60M$10.75M$12.09M$10.46M$11.39M$14.07M$16.19M$19.09M$18.19M$17.48M$13.82M$10.44M$11.12M$10.18M$9.44M$8.33M$8.02M$7.66M$7.17M$5.08M$11.18M$11.50M$14.46M$13.37M$12.19M$19.58M$13.36M
Low Forecast$12.33M$12.47M$12.57M$11.75M$10.03M$12.09M$10.46M$11.39M$13.13M$16.19M$17.81M$16.98M$16.32M$13.82M$10.44M$11.12M$10.18M$9.44M$8.33M$8.02M$7.66M$7.17M$5.08M$11.18M$11.50M$14.46M$13.37M$12.19M$13.06M$8.91M
# Analysts111111111111111111111115998812161913
Surprise %--------0.98%1.06%1.08%1.27%1.06%1.29%1.21%0.87%1.09%1.13%1.12%1.04%1.01%1.02%1.04%0.92%0.97%0.81%0.85%0.95%0.75%1.26%

TransAct's average Quarter revenue forecast for Mar 24 based on 1 analysts is $11.39M, with a low forecast of $11.39M, and a high forecast of $11.39M. TACT's average Quarter revenue forecast represents a -14.17% decrease compared to the company's last Quarter revenue of $13.27M (Dec 23).

TransAct EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
# Analysts111111111111111111111115998812161913
EBITDA--------$-136.00K$1.19M$1.22M$3.81M$494.00K$387.00K$-2.95M$-5.18M$-913.00K$677.00K$-2.58M$-2.54M$-1.98M$-1.14M$-2.54M$-1.22M$-269.00K$500.00K$403.00K$1.12M$1.09M$1.71M
Avg Forecast$-809.04K$-818.58K$-824.88K$-771.40K$-658.47K$-766.05K$-662.90K$-3.72M$-861.69K$-1.03M$-1.17M$-3.38M$1.99M$-1.48M$-1.11M$-3.07M$-1.09M$-1.01M$-890.09K$-2.43M$-818.58K$-766.03K$-542.20K$-501.60K$-1.23M$-1.54M$-1.43M$-1.30M$1.36M$1.27M
High Forecast$-781.04K$-790.25K$-796.34K$-744.71K$-635.68K$-766.03K$-662.88K$-2.97M$-831.87K$-1.03M$-1.13M$-2.70M$2.39M$-1.48M$-1.11M$-2.46M$-1.09M$-1.01M$-890.09K$-1.94M$-818.58K$-766.03K$-542.20K$-401.28K$-1.23M$-1.54M$-1.43M$-1.30M$1.63M$1.53M
Low Forecast$-837.04K$-846.90K$-853.42K$-798.10K$-681.25K$-766.07K$-662.92K$-4.46M$-891.51K$-1.03M$-1.21M$-4.06M$1.59M$-1.48M$-1.11M$-3.69M$-1.09M$-1.01M$-890.09K$-2.92M$-818.58K$-766.03K$-542.20K$-601.92K$-1.23M$-1.54M$-1.43M$-1.30M$1.09M$1.02M
Surprise %--------0.16%-1.16%-1.05%-1.13%0.25%-0.26%2.65%1.68%0.84%-0.67%2.90%1.04%2.42%1.49%4.69%2.42%0.22%-0.32%-0.28%-0.86%0.80%1.34%

1 analysts predict TACT's average Quarter EBITDA for Dec 23 to be $-861.69K, with a high of $-831.87K and a low of $-891.51K. This is -172.35% lower than TransAct's previous annual EBITDA (Sep 23) of $1.19M.

TransAct Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
# Analysts111111111111111111111115998812161913
Net Income--------$-62.00K$906.00K$1.55M$3.14M$260.00K$528.00K$-2.38M$-4.01M$-735.00K$910.00K$-2.11M$-2.21M$-1.92M$-867.00K$-1.85M$-992.00K$-800.00K$384.00K$186.00K$746.00K$680.00K$943.00K
Avg Forecast$-150.09K$-100.06K$-100.06K$-600.36K$-950.57K$-800.48K$-1.60M$-3.24M$-350.21K$-100.06K$650.39K$-2.94M$-564.10K$-1.90M$-3.07M$-2.67M$-2.22M$-2.77M$-2.55M$-2.11M$-1.35M$-1.50M$-3.40M$-409.20K$299.91K$2.10M$1.20M$499.85K$850.00K$700.63K
High Forecast$-143.34K$-95.56K$-95.56K$-573.35K$-907.81K$-764.47K$-1.53M$-2.59M$-334.45K$-95.56K$679.65K$-2.35M$-451.28K$-1.90M$-3.07M$-2.14M$-2.22M$-2.77M$-2.55M$-1.69M$-1.35M$-1.50M$-3.40M$-327.36K$299.91K$2.10M$1.20M$499.85K$1.02M$840.76K
Low Forecast$-156.84K$-104.56K$-104.56K$-627.37K$-993.33K$-836.49K$-1.67M$-3.88M$-365.96K$-104.56K$621.13K$-3.53M$-676.92K$-1.90M$-3.07M$-3.21M$-2.22M$-2.77M$-2.55M$-2.54M$-1.35M$-1.50M$-3.40M$-491.04K$299.91K$2.10M$1.20M$499.85K$680.00K$560.51K
Surprise %--------0.18%-9.05%2.38%-1.07%-0.46%-0.28%0.78%1.50%0.33%-0.33%0.83%1.04%1.42%0.58%0.55%2.42%-2.67%0.18%0.16%1.49%0.80%1.35%

TransAct's average Quarter net income forecast for Dec 23 is $-350.21K, with a range of $-365.96K to $-334.45K. TACT's average Quarter net income forecast represents a -138.65% decrease compared to the company's last Quarter net income of $906.00K (Sep 23).

TransAct SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
# Analysts111111111111111111111115998812161913
SG&A--------$4.73M$5.22M$7.13M$6.17M$5.59M$5.82M$6.22M$5.89M$4.91M$4.04M$4.28M$4.05M$3.53M$3.38M$3.66M$4.83M$4.59M$4.19M$4.28M$4.14M$3.79M$3.68M
Avg Forecast$5.22M$5.28M$5.32M$4.97M$4.25M$4.94M$4.27M$5.94M$5.56M$6.62M$7.54M$5.40M$11.37M$5.64M$4.26M$4.91M$4.16M$3.86M$3.40M$3.88M$3.13M$2.93M$2.07M$1.99M$4.70M$5.91M$5.46M$4.98M$4.73M$2.74M
High Forecast$5.40M$5.46M$5.50M$5.15M$4.39M$4.94M$4.27M$7.13M$5.75M$6.62M$7.80M$6.48M$13.64M$5.64M$4.26M$5.89M$4.16M$3.86M$3.40M$4.66M$3.13M$2.93M$2.07M$2.39M$4.70M$5.91M$5.46M$4.98M$5.68M$3.28M
Low Forecast$5.04M$5.10M$5.13M$4.80M$4.10M$4.94M$4.27M$4.76M$5.36M$6.62M$7.28M$4.32M$9.10M$5.64M$4.26M$3.93M$4.16M$3.86M$3.40M$3.11M$3.13M$2.93M$2.07M$1.59M$4.70M$5.91M$5.46M$4.98M$3.79M$2.19M
Surprise %--------0.85%0.79%0.95%1.14%0.49%1.03%1.46%1.20%1.18%1.05%1.26%1.04%1.13%1.15%1.77%2.42%0.98%0.71%0.78%0.83%0.80%1.35%

TransAct's average Quarter SG&A projection for Mar 24 is $5.94M, based on 1 Wall Street analysts, with a range of $4.76M to $7.13M. The forecast indicates a 25.55% rise compared to TACT last annual SG&A of $4.73M (Dec 23).

TransAct EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
# Analysts111111111111111111111115998812161913
EPS--------$-0.01$0.09$0.16$0.32$0.03$0.05$-0.24$-0.41$-0.07$0.10$-0.24$-0.25$-0.22$-0.11$-0.25$-0.13$-0.11$0.05$0.02$0.10$0.09$0.13
Avg Forecast$-0.01$-0.01$-0.01$-0.06$-0.10$-0.08$-0.16$-0.15$-0.04$-0.01$0.07$0.03$-0.01$-0.19$-0.31$-0.19$-0.22$-0.28$-0.26$-0.23$-0.14$-0.15$-0.34$-0.08$0.03$0.21$0.12$0.05$0.15$0.05
High Forecast$-0.01$-0.01$-0.01$-0.06$-0.09$-0.08$-0.15$-0.14$-0.03$-0.01$0.07$0.03$-0.00$-0.19$-0.31$-0.19$-0.22$-0.28$-0.26$-0.23$-0.14$-0.15$-0.34$-0.08$0.03$0.21$0.12$0.05$0.18$0.06
Low Forecast$-0.02$-0.01$-0.01$-0.06$-0.10$-0.08$-0.17$-0.16$-0.04$-0.01$0.06$0.03$-0.01$-0.19$-0.31$-0.19$-0.22$-0.28$-0.26$-0.23$-0.14$-0.15$-0.34$-0.08$0.03$0.21$0.12$0.05$0.12$0.04
Surprise %--------0.18%-9.00%2.46%10.67%-6.00%-0.26%0.78%2.13%0.34%-0.36%0.94%1.09%1.63%0.73%0.74%1.63%-3.67%0.24%0.17%2.00%0.60%2.60%

According to 1 Wall Street analysts, TransAct's projected average Quarter EPS for Dec 23 is $-0.04, with a low estimate of $-0.04 and a high estimate of $-0.03. This represents a -138.89% decrease compared to TACT previous annual EPS of $0.09 (Sep 23).

TransAct Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
TACTTransAct$4.03$9.00123.33%Buy
FAROFARO$27.60$26.00-5.80%Buy

TACT Forecast FAQ


Is TransAct a good buy?

Yes, according to 1 Wall Street analysts, TransAct (TACT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of TACT's total ratings.

What is TACT's price target?

TransAct (TACT) average price target is $9 with a range of $9 to $9, implying a 126.70% from its last price of $3.97. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will TransAct stock go up soon?

According to Wall Street analysts' prediction for TACT stock, the company can go up by 126.70% (from the last price of $3.97 to the average price target of $9), up by 126.70% based on the highest stock price target, and up by 126.70% based on the lowest stock price target.

Can TransAct stock reach $6?

TACT's average twelve months analyst stock price target of $9 supports the claim that TransAct can reach $6 in the near future.

What are TransAct's analysts' financial forecasts?

TransAct's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $44.33M (high $44.69M, low $43.97M), average EBITDA is $-5.806M (high $-5.039M, low $-6.572M), average net income is $-6.588M (high $-5.79M, low $-7.386M), average SG&A $19.4M (high $20.74M, low $18.07M), and average EPS is $-0.485 (high $-0.463, low $-0.507). TACT's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $50.88M (high $52.64M, low $49.12M), average EBITDA is $-3.224M (high $-3.112M, low $-3.335M), average net income is $-951K (high $-908K, low $-993K), average SG&A $20.79M (high $21.51M, low $20.07M), and average EPS is $-0.095 (high $-0.0907, low $-0.0993).

Did the TACT's actual financial results beat the analysts' financial forecasts?

Based on TransAct's last annual report (Dec 2023), the company's revenue was $72.63M, beating the average analysts forecast of $65.83M by 10.33%. Apple's EBITDA was $5.71M, missing the average prediction of $-6.437M by -188.64%. The company's net income was $4.75M, missing the average estimation of $-2.742M by -273.18%. Apple's SG&A was $23.25M, missing the average forecast of $25.11M by -7.41%. Lastly, the company's EPS was $0.47, beating the average prediction of $0.05 by 840.00%. In terms of the last quarterly report (Dec 2023), TransAct's revenue was $13.26M, missing the average analysts' forecast of $13.6M by -2.46%. The company's EBITDA was $-136K, missing the average prediction of $-862K by -84.22%. TransAct's net income was $-62K, missing the average estimation of $-350K by -82.30%. The company's SG&A was $4.73M, missing the average forecast of $5.56M by -14.80%. Lastly, the company's EPS was $-0.0062, missing the average prediction of $-0.035 by -82.29%